Related Experiment Video

Updated: Aug 14, 2026

Magnetic Isolation of Microglial Cells from Neonate Mouse for Primary Cell Cultures
07:23

Magnetic Isolation of Microglial Cells from Neonate Mouse for Primary Cell Cultures

Published on: July 25, 2022

Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IkappaBalpha degradation in a

Maria Nikodemova1, Ian D Duncan, Jyoti J Watters

  • 1Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin 53706, USA. nikodemova@svm.vetmed.wisc.edu

Journal of Neurochemistry
|December 13, 2005
PubMed

Insights

Minocycline, an anti-inflammatory drug, inhibits microglial activation by blocking specific mitogen-activated protein kinase (MAPK) pathways and nuclear factor-kappaB (NF-kappaB) signaling. Its effectiveness varies depending on the stimulus used.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Central nervous system (CNS) inflammation, driven by microglial activation, contributes to neurodegeneration.
  • Minocycline, a tetracycline derivative, exhibits anti-inflammatory effects in the CNS by modulating microglial activity.
  • Mitogen-activated protein kinase (MAPK) and nuclear factor-kappaB (NF-kappaB) pathways are key regulators of microglial activation and inflammatory mediator production.

Purpose of the Study:

  • To investigate the effects of minocycline on the activation of specific MAPKs (p38, JNK1/2, ERK1/2) and NF-kappaB signaling in microglial cells.
  • To determine if minocycline's inhibitory effects on MAPKs are stimulus-dependent.
  • To explore potential mechanisms underlying minocycline's action, including protein kinase C (PKC) involvement.

Main Methods:

  • Experiments were conducted using BV-2 and primary microglial cells.
  • Cells were stimulated with various agents (lipopolysaccharide, H2O2, adenosine triphosphate) to activate MAPK pathways.
  • Minocycline's impact on MAPK activation (p38, JNK1/2, ERK1/2) and inhibitor alpha of NF-kappaB (IkappaBalpha) degradation was assessed.

Main Results:

  • Minocycline inhibited lipopolysaccharide-stimulated MAPK activation but not H2O2-activated MAPKs.
  • The drug selectively inhibited JNK1/2 and ERK1/2, but not p38, when cells were stimulated with adenosine triphosphate.
  • Minocycline attenuated lipopolysaccharide-induced IkappaBalpha degradation, suggesting inhibition of NF-kappaB transcriptional activity.
  • Evidence suggests a partial role for protein kinase C (PKC) inhibition in minocycline's MAPK inhibitory mechanism.

Conclusions:

  • Minocycline demonstrates stimulus-specific inhibition of MAPK pathways in microglial cells.
  • The drug interferes with key signaling cascades involved in neuroinflammation.
  • These findings support minocycline's potential therapeutic role in neurodegenerative and demyelinating diseases characterized by microglial activation.

More Related Videos

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...